BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9754908)

  • 1. Modulation of serum histamine releasing activity in chronic idiopathic urticaria.
    Zweiman B; Valenzano M; Atkins PC
    Immunopharmacology; 1998 Jun; 39(3):225-34. PubMed ID: 9754908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria.
    Zweiman B; Valenzano M; Atkins PC; Tanus T; Getsy JA
    J Allergy Clin Immunol; 1996 Jul; 98(1):89-98. PubMed ID: 8765822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic urticaria: novel clinical and serological aspects.
    Asero R; Tedeschi A; Lorini M; Salimbeni R; Zanoletti T; Miadonna A
    Clin Exp Allergy; 2001 Jul; 31(7):1105-10. PubMed ID: 11468002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
    Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
    Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
    Vonakis BM; Vasagar K; Gibbons SP; Gober L; Sterba PM; Chang H; Saini SS
    J Allergy Clin Immunol; 2007 Feb; 119(2):441-8. PubMed ID: 17125820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of in vivo basophil activation in chronic idiopathic urticaria.
    Vasagar K; Vonakis BM; Gober LM; Viksman A; Gibbons SP; Saini SS
    Clin Exp Allergy; 2006 Jun; 36(6):770-6. PubMed ID: 16776678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera.
    Ferrer M; Luquin E; Kaplan AP
    Allergy; 2003 Aug; 58(8):802-7. PubMed ID: 12859562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.
    Sabroe RA; Francis DM; Barr RM; Black AK; Greaves MW
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):651-8. PubMed ID: 9802375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors.
    White MV; Kaplan AP; Haak-Frendscho M; Kaliner M
    J Immunol; 1988 Nov; 141(10):3575-83. PubMed ID: 2460539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria.
    Fagiolo U; Kricek F; Ruf C; Peserico A; Amadori A; Cancian M
    J Allergy Clin Immunol; 2000 Sep; 106(3):567-72. PubMed ID: 10984379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria.
    Grattan CE; Francis DM; Hide M; Greaves MW
    Clin Exp Allergy; 1991 Nov; 21(6):695-704. PubMed ID: 1723343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of basophil histamine release by tyrosine kinase and phosphatidylinositol 3-kinase inhibitors.
    Tedeschi A; Lorini M; Galbiati S; Gibelli S; Miadonna A
    Int J Immunopharmacol; 2000 Oct; 22(10):797-808. PubMed ID: 10963852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
    Niimi N; Francis DM; Kermani F; O'Donnell BF; Hide M; Kobza-Black A; Winkelmann RK; Greaves MW; Barr RM
    J Invest Dermatol; 1996 May; 106(5):1001-6. PubMed ID: 8618029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic urticaria sera increase basophil CD203c expression.
    Yasnowsky KM; Dreskin SC; Efaw B; Schoen D; Vedanthan PK; Alam R; Harbeck RJ
    J Allergy Clin Immunol; 2006 Jun; 117(6):1430-4. PubMed ID: 16751009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basophil histamine release activity and disease severity in chronic idiopathic urticaria.
    Baker R; Vasagar K; Ohameje N; Gober L; Chen SC; Sterba PM; Saini SS
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):244-9. PubMed ID: 18426144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity.
    Grattan CE; Walpole D; Francis DM; Niimi N; Dootson G; Edler S; Corbett MF; Barr RM
    Clin Exp Allergy; 1997 Dec; 27(12):1417-24. PubMed ID: 9433937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity.
    Sabroe RA; Fiebiger E; Francis DM; Maurer D; Seed PT; Grattan CE; Black AK; Stingl G; Greaves MW; Barr RM
    J Allergy Clin Immunol; 2002 Sep; 110(3):492-9. PubMed ID: 12209101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE.
    MacDonald SM; Lichtenstein LM; Proud D; Plaut M; Naclerio RM; MacGlashan DW; Kagey-Sobotka A
    J Immunol; 1987 Jul; 139(2):506-12. PubMed ID: 2439589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mechanisms of IL-3 induced histamine release and IL-3 priming effect on human basophils.
    Okayama Y; Begishvili TB; Church MK
    Clin Exp Allergy; 1993 Nov; 23(11):901-10. PubMed ID: 10779277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression--inhibitory effects ofanti-inflammatory drugs.
    Wedi B; Novacovic V; Koerner M; Kapp A
    J Allergy Clin Immunol; 2000 Mar; 105(3):552-60. PubMed ID: 10719307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.